nobiletin and Dyslipidemia
nobiletin has been researched along with Dyslipidemia in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Choi, MS; Jeong, MJ; Jung, UJ; Kim, SR; Kim, YJ; Woo, JT | 1 |
Allister, EM; Assini, JM; Charbonneau, A; Edwards, JY; Huff, MW; Koppes, JB; Lee, JK; Marette, A; Mulvihill, EE; Sawyez, CG; St-Pierre, P; Sutherland, BG; Telford, DE | 1 |
Assini, JM; Huff, MW; Mulvihill, EE | 1 |
Reviews
1 review(s) available for nobiletin and Dyslipidemia
Article | Year |
---|---|
Citrus flavonoids and lipid metabolism.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Citrus; Dyslipidemias; Flavanones; Flavones; Hesperidin; Humans; Hypolipidemic Agents; Inflammation; Lipid Metabolism; Oxidation-Reduction; Phytotherapy | 2013 |
Other Studies
2 other study(ies) available for nobiletin and Dyslipidemia
Article | Year |
---|---|
Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity.
Topics: Adipose Tissue; Animals; Body Weight; Cytokines; Diet, High-Fat; Dietary Supplements; Dyslipidemias; Flavones; Hepatitis; Insulin Resistance; Lipids; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity | 2017 |
Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance.
Topics: Animals; Atherosclerosis; Butadienes; Diet; Dyslipidemias; Electrophoresis, Polyacrylamide Gel; Energy Metabolism; Enzyme Inhibitors; Flavones; Hep G2 Cells; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipoproteins, VLDL; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Mutant Strains; Nitriles; Phosphorylation; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Triglycerides | 2011 |